Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.31 |
| ▸ | MMP7 | P09237 | 2/20 | 0.31 |
| ▸ | MMP8 | P22894 | 2/20 | 0.31 |
| ▸ | MMP12 | P39900 | 2/20 | 0.31 |
| ▸ | MMP13 | P45452 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | APLNR | P35414 | 1/20 | 0.30 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16261608 | 0.90 | CA1 (0.50) | SMN1; SMN2MAPTCA1KMT2ACA12 | |
| SCHEMBL8241145 | 0.87 | SMN1; SMN2 (0.35) | SMN1; SMN2MAPTALDH1A1CA1CA12 | |
| SCHEMBL14592835 | 0.84 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL5176138 | 0.77 | MAPT (0.38) | SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL2595019 | 0.76 | TSHR (0.43) | MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL20173258 | 0.75 | — | — | |
| Ethane SCHEMBL4345451 | 0.74 | SMN1; SMN2 (0.38) | SMN1; SMN2MAPTCA1NPC1GAA | |
| SCHEMBL796093 | 0.74 | — | — | |
| SCHEMBL4437562 | 0.74 | CA1 (0.43) | SMN1; SMN2MAPTALDH1A1CA1NPC1 | |
| SCHEMBL8654027 | 0.74 | CA1 (0.43) | SMN1; SMN2ALDH1A1CA1MMP1MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8870339-B2 | Inkjet image forming method | FUJIFILM CORPORATION (JP) | 2014-10-28 | — | — | US | disclosed |
| US-8148358-B2 | Blue colour filters with enhanced contrast | BASF SE (DE) | 2012-04-03 | — | — | US | disclosed |
| US-8148358-B2 | Blue colour filters with enhanced contrast | BASF SE (DE) | 2012-04-03 | — | — | US | disclosed |
| US-20110242197-A1 | Magenta Dyes and Inks for Use in Ink-Jet Printing | Fujifilm Imaging Colorants, Limited (GB) | 2011-10-06 | — | — | US | disclosed |
| US-8017608-B2 | 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors | NOVARTIS AG (CH) | 2011-09-13 | — | — | US | disclosed |
| US-8017608-B2 | 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors | NOVARTIS AG (CH) | 2011-09-13 | — | — | US | disclosed |
| US-20110205290-A1 | INKJET IMAGE FORMING METHOD | FUJIFILM CORPORATION (JP) | 2011-08-25 | — | — | US | disclosed |
| US-20110168053-A1 | Weather-Resistant Dye And Use Thereof | NINESTAR MANAGEMENT CO., LTD. (CN) | 2011-07-14 | — | — | US | disclosed |
| US-20100227199-A1 | Blue Colour Filters with Enhanced Contrast | CIBA CORPORATION | 2010-09-09 | — | — | US | disclosed |
| US-20100227199-A1 | Blue Colour Filters with Enhanced Contrast | CIBA CORPORATION | 2010-09-09 | — | — | US | disclosed |
| EP-1608647-B1 | 5-PHENYLTHIAZOLE DERIVATIVES AND THEIR USE AS P13 KINASE INHIBITORS | NOVARTIS AG (CH) | 2008-01-09 | — | — | EP | disclosed |
| US-5095044-A | Odorless, discoloration inhibition | CIBA-GEIGY CORPORATION (US) | 1992-03-10 | — | — | US | disclosed |
| US-4950795-A | PRINTING PLATES, PAPER COATING | CIBA-GEIGY CORPORATION (US) | 1990-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227199-A1 | Blue Colour Filters with Enhanced Contrast | NR1H4, NR1D1, NR1D2 | SMN1; SMN2 3125/4885MAPT 3802/4885ALDH1A1 529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.